StockTipsArenaBeta

BUY AstraZeneca Pharma India Ltd. — Madhu Bansal

BUYAstraZeneca Pharma India Ltd.
AstraZeneca Pharma India share price target & all analyst calls

byMadhu BansalHorizon: NA (inferred Swing (≤2wk))16 Sept 2026via CNBC Awaaz.

Entry₹6,825Inferred
Target₹7,428
Total upside +8.84% (call closed)
Stop loss₹6,615-3.08% risk
Exit₹6,61522 Sept 2026, 9:15 am
Stop-loss hit-3.08%
Follow Madhu Bansal for new calls(23% target hit, 52 closed calls)Get alertsWatch ASTRAZEN for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 22 Sept 2026
0 supporting1 neutral1 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (1)

AstraZeneca Pharma India accepts resignation of Dr. Sandeep Arora

NewsGoogle News·15 Sept · 6d ago

(opens in new tab)
Weighs against the BUY call (1)

AstraZeneca's Breast Cancer Drug Etcamah Fails SERENA-4 Trial

NewsGoogle News·12 Sept · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on AstraZeneca Pharma India

All analyst calls on AstraZeneca Pharma India

More from Madhu Bansal

Every call and its outcome